Clinical studies management & pharmacovigilance strategies
We are sorry, this workshop is fully booked
Documents
- 1._introduction_dcvmn-pv.pdf (PDF - 7.3 Mb)
- 2_-_overview_of_regulatory_requirements_and_pv_systems_reformat.pdf (PDF - 279.3 kb)
- 3_-_fundamentals_of_an_effective_pv_system_reformat.pdf (PDF - 343.5 kb)
- 5_-_signal_identification_and_assessment_reformat.pdf (PDF - 302.6 kb)
- 6._psurs_dcvmn-pv.pdf (PDF - 1.7 Mb)
- 7._rmp_dcvmn-vp.pdf (PDF - 1.5 Mb)
- agenda_bali_workshop_july_17-21_v3a.pdf (PDF - 113.9 kb)
- clinical_development_plan18july2016_to_be_sent.pdf (PDF - 2.5 Mb)
- dcvmn_bali_pharmacovigilance_pre-reading.pdf (PDF - 1.3 Mb)
- e6ich_gcp.pdf (PDF - 380 kb)
- emea_note_guidanceclinical_evaluation_vaccines.pdf (PDF - 236.5 kb)
- from_protocol_to_csr_dcvmnjuly2016.pdf (PDF - 1.9 Mb)
- how_to_design_a_clinical_trial_general_principles17july2016.pdf (PDF - 1.9 Mb)
- how_to_write_a_clinical_protocol.pdf (PDF - 1 Mb)
- ich_gcp__dcvmn_training_july2016.pdf (PDF - 3.9 Mb)
- overview_on_vaccine_clinical_development.pdf (PDF - 758.6 kb)
- reportingcinicaltrialresults_dcvmn-training2016.pdf (PDF - 1.8 Mb)
- who_trs_924_clinical_evaluation_035-101.2004_1_-2.pdf (PDF - 312.6 kb)
- writing_a_clinical_development_plan.pdf (PDF - 446.4 kb)
